Overview
Porencephaly (also known as porencephalic cyst or familial porencephaly) is a rare neurological condition characterized by the presence of fluid-filled cysts or cavities within the brain parenchyma, typically communicating with the lateral ventricles and/or the subarachnoid space. These cavities most commonly result from destruction of brain tissue and can occur due to vascular events (such as prenatal stroke), infections, trauma, or genetic causes. Familial porencephaly (type 1, OMIM 175780) is caused by heterozygous mutations in the COL4A1 gene on chromosome 13q34, while porencephaly type 2 (OMIM 614483) is associated with mutations in the COL4A2 gene. These genes encode components of type IV collagen, which is critical for the structural integrity of blood vessel basement membranes, making affected individuals susceptible to hemorrhagic events in the developing brain. The clinical presentation of porencephaly is highly variable, depending on the size, location, and number of cysts. Common manifestations include hemiplegia or hemiparesis (weakness on one side of the body), seizures (including infantile spasms), intellectual disability, developmental delay, speech and language difficulties, and hydrocephalus. Some individuals may have relatively mild symptoms, while others experience severe neurological impairment. Additional features in familial forms related to COL4A1/COL4A2 mutations may include small vessel disease, migraine with aura, Raynaud phenomenon, and eye abnormalities such as retinal arteriolar tortuosity. There is no cure for porencephaly, and treatment is primarily supportive and symptomatic. Management may include anticonvulsant medications for seizure control, physical and occupational therapy for motor deficits, speech therapy, and special education services. In cases complicated by progressive hydrocephalus, neurosurgical intervention such as ventriculoperitoneal shunt placement or cyst fenestration may be necessary. Genetic counseling is recommended for families with the hereditary form. Prognosis varies widely based on the extent of brain involvement and the underlying etiology.
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Porencephaly.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Porencephaly at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Porencephaly.
Community
No community posts yet. Be the first to share your experience with Porencephaly.
Start the conversation →Latest news about Porencephaly
No recent news articles for Porencephaly.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Porencephaly
What is Porencephaly?
Porencephaly (also known as porencephalic cyst or familial porencephaly) is a rare neurological condition characterized by the presence of fluid-filled cysts or cavities within the brain parenchyma, typically communicating with the lateral ventricles and/or the subarachnoid space. These cavities most commonly result from destruction of brain tissue and can occur due to vascular events (such as prenatal stroke), infections, trauma, or genetic causes. Familial porencephaly (type 1, OMIM 175780) is caused by heterozygous mutations in the COL4A1 gene on chromosome 13q34, while porencephaly type 2
At what age does Porencephaly typically begin?
Typical onset of Porencephaly is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Porencephaly?
1 specialists and care centers treating Porencephaly are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.